Michelle Linterman

Last updated

Michelle Linterman
Born
Michelle Linterman

Christchurch, New Zealand
Alma mater Victoria University of Wellington
Australian National University
Scientific career
Institutions Babraham Institute
Thesis Roquin controls germinal center formation and tolerance  (2009)

Michelle Linterman (born 1983) is a New Zealand immunologist. She is a group leader at the Babraham Institute in the United Kingdom, where she researches the biology of the germinal center response after immunisation and infection.

Contents

Early life and education

Linterman was born in Christchurch, New Zealand, the daughter of Louisa and Robert Linterman, and grew up in Waikanae. [1] She undertook undergraduate studies in biomedical sciences at Victoria University of Wellington (VUW) at the same time that a scientific revolution was occurring in genetics, [1] and graduated with a Bachelor of Biomedical Sciences degree in 2005. [2]

Linterman went to Canberra and completed a summer studentship with Carola Vinuesa at the Australian National University (ANU). Linterman ended up staying at ANU for a year to work on human genetics, before deciding to complete a doctorate. She started working with genetically modified mice to better understand disease. Using these mice, Vinuesa had just discovered RC3H1, and Linterman decided to study why these mice had a systemic lupus–like disease. At the time, follicular B helper T cells (Tfh) were starting to attract considerable research interest. Tfh are critical for germinal centre formation, and mice in Linterman's lab (with the Roquinsan/sansanroque mutation) spontaneously formed Tfh cells that contributed to the systemic lupus erythematosus that plagued these mice. [1] [3] She discovered that a proportion of these Tfh cells expressed FOXP3, a transcription factor involved in immune system responses. [1]

Linterman moved to the University of Cambridge as a postdoctoral researcher, where she studied the fundamental biology of Tfh cells. [4] [5] Still fascinated by the mechanisms that underpin FOXP3 regulation, Linterman started exploring Tfh cells in vivo. [6]

Research and career

Linterman formed a research group at the Babraham Institute, where she studies germinal centre biology and how the immune system responds to vaccination. [7] [8] Germinal centres are sites within biological tissue (e.g. in the spleen, tonsils and lymph nodes) where B cells reproduce, replicate and differentiate as the immune system responds to infection. The germinal centre teaches the immune system how to respond more rapidly and effectively to future pathogens, and is critical for effective response to vaccination. The magnitude of the germinal centre response diminishes with age, largely due to the role of T cells. [9] Linterman investigates the role of the germinal centre in ageing, and how they form non-lymphoid tissues. [10] She found that a cascade of events creates germinal centres that help to create cross-reactive antibodies. [11]

In 2019, Linterman was awarded the Lister Institute Research Prize Fellowship for her efforts to understand the flu infection. [11] [12] She discovered that the body remodels lung tissue to contribute to the immune system response and produce more antibodies. [11]

Selected publications

Related Research Articles

<span class="mw-page-title-main">B cell</span> Type of white blood cell

B cells, also known as B lymphocytes, are a type of white blood cell of the lymphocyte subtype. They function in the humoral immunity component of the adaptive immune system. B cells produce antibody molecules which may be either secreted or inserted into the plasma membrane where they serve as a part of B-cell receptors. When a naïve or memory B cell is activated by an antigen, it proliferates and differentiates into an antibody-secreting effector cell, known as a plasmablast or plasma cell. In addition, B cells present antigens and secrete cytokines. In mammals, B cells mature in the bone marrow, which is at the core of most bones. In birds, B cells mature in the bursa of Fabricius, a lymphoid organ where they were first discovered by Chang and Glick, which is why the B stands for bursa and not bone marrow, as commonly believed.

<span class="mw-page-title-main">Memory B cell</span> Cell of the adaptive immune system

In immunology, a memory B cell (MBC) is a type of B lymphocyte that forms part of the adaptive immune system. These cells develop within germinal centers of the secondary lymphoid organs. Memory B cells circulate in the blood stream in a quiescent state, sometimes for decades. Their function is to memorize the characteristics of the antigen that activated their parent B cell during initial infection such that if the memory B cell later encounters the same antigen, it triggers an accelerated and robust secondary immune response. Memory B cells have B cell receptors (BCRs) on their cell membrane, identical to the one on their parent cell, that allow them to recognize antigen and mount a specific antibody response.

<span class="mw-page-title-main">Complement receptor 1</span> Protein found in humans

Complement receptor type 1 (CR1) also known as C3b/C4b receptor or CD35 is a protein that in humans is encoded by the CR1 gene.

The regulatory T cells (Tregs or Treg cells), formerly known as suppressor T cells, are a subpopulation of T cells that modulate the immune system, maintain tolerance to self-antigens, and prevent autoimmune disease. Treg cells are immunosuppressive and generally suppress or downregulate induction and proliferation of effector T cells. Treg cells express the biomarkers CD4, FOXP3, and CD25 and are thought to be derived from the same lineage as naïve CD4+ cells. Because effector T cells also express CD4 and CD25, Treg cells are very difficult to effectively discern from effector CD4+, making them difficult to study. Research has found that the cytokine transforming growth factor beta (TGF-β) is essential for Treg cells to differentiate from naïve CD4+ cells and is important in maintaining Treg cell homeostasis.

<span class="mw-page-title-main">Germinal center</span> Lymphatic tissue structure

Germinal centers or germinal centres (GCs) are transiently formed structures within B cell zone (follicles) in secondary lymphoid organs – lymph nodes, ileal Peyer's patches, and the spleen – where mature B cells are activated, proliferate, differentiate, and mutate their antibody genes during a normal immune response; most of the germinal center B cells (BGC) are removed by tingible body macrophages. There are several key differences between naive B cells and GC B cells, including level of proliferative activity, size, metabolic activity and energy production. The B cells develop dynamically after the activation of follicular B cells by T-dependent antigen. The initiation of germinal center formation involves the interaction between B and T cells in the interfollicular area of the lymph node, CD40-CD40L ligation, NF-kB signaling and expression of IRF4 and BCL6.

<span class="mw-page-title-main">Interleukin 7</span> Growth factor secreted by stromal cells in the bone marrow and thymus.

Interleukin 7 (IL-7) is a protein that in humans is encoded by the IL7 gene.

<span class="mw-page-title-main">CD154</span> Protein-coding gene in humans

CD154, also called CD40 ligand or CD40L, is a protein that is primarily expressed on activated T cells and is a member of the TNF superfamily of molecules. It binds to CD40 on antigen-presenting cells (APC), which leads to many effects depending on the target cell type. In total CD40L has three binding partners: CD40, α5β1 integrin and integrin αIIbβ3. CD154 acts as a costimulatory molecule and is particularly important on a subset of T cells called T follicular helper cells. On TFH cells, CD154 promotes B cell maturation and function by engaging CD40 on the B cell surface and therefore facilitating cell-cell communication. A defect in this gene results in an inability to undergo immunoglobulin class switching and is associated with hyper IgM syndrome. Absence of CD154 also stops the formation of germinal centers and therefore prohibiting antibody affinity maturation, an important process in the adaptive immune system.

<span class="mw-page-title-main">Complement receptor 2</span> Protein found in humans

Complement receptor type 2 (CR2), also known as complement C3d receptor, Epstein-Barr virus receptor, and CD21, is a protein that in humans is encoded by the CR2 gene.

<span class="mw-page-title-main">Follicular dendritic cells</span> Immune cells found in lymph nodes

Follicular dendritic cells (FDC) are cells of the immune system found in primary and secondary lymph follicles of the B cell areas of the lymphoid tissue. Unlike dendritic cells (DC), FDCs are not derived from the bone-marrow hematopoietic stem cell, but are of mesenchymal origin. Possible functions of FDC include: organizing lymphoid tissue's cells and microarchitecture, capturing antigen to support B cell, promoting debris removal from germinal centers, and protecting against autoimmunity. Disease processes that FDC may contribute include primary FDC-tumor, chronic inflammatory conditions, HIV-1 infection development, and neuroinvasive scrapie.

<span class="mw-page-title-main">CD278</span> Protein-coding gene in the species Homo sapiens

Inducible T-cell costimulator is an immune checkpoint protein that in humans is encoded by the ICOS gene. The protein belongs to the CD28 and CTLA-4 cell-surface receptor family. These are proteins expressed on the surface of immune cells that mediate signalling between them. A surface protein, the ligand, binds specifically to its receptor on another cell, leading to a signalling cascade in that cell.

<span class="mw-page-title-main">CXCL13</span> Mammalian protein found in Homo sapiens

Chemokineligand 13 (CXCL13), also known as B lymphocyte chemoattractant (BLC) or B cell-attracting chemokine 1 (BCA-1), is a protein ligand that in humans is encoded by the CXCL13 gene.

<span class="mw-page-title-main">BCL6</span> Transcription factor for converting Naive T cells to TFH

Bcl-6 is a protein that in humans is encoded by the BCL6 gene. BCL6 is a master transcription factor for regulation of T follicular helper cells proliferation. BCL6 has three evolutionary conserved structural domains. The interaction of these domains with corepressors allows for germinal center development and leads to B cell proliferation.

<span class="mw-page-title-main">TOX</span> Protein-coding gene in the species Homo sapiens

Thymocyte selection-associated high mobility group box protein TOX is a protein that in humans is encoded by the TOX gene. TOX drives T-cell exhaustion and plays a role in innate lymphoid cell development.

<span class="mw-page-title-main">Follicular B helper T cells</span>

Follicular helper T cells (also known as T follicular helper cells and abbreviated as TFH), are antigen-experienced CD4+ T cells found in the periphery within B cell follicles of secondary lymphoid organs such as lymph nodes, spleen and Peyer's patches, and are identified by their constitutive expression of the B cell follicle homing receptor CXCR5. Upon cellular interaction and cross-signaling with their cognate follicular (Fo B) B cells, TFH cells trigger the formation and maintenance of germinal centers through the expression of CD40 ligand (CD40L) and the secretion of IL-21 and IL-4. TFH cells also migrate from T cell zones into these seeded germinal centers, predominantly composed of rapidly dividing B cells mutating their Ig genes. Within germinal centers, TFH cells play a critical role in mediating the selection and survival of B cells that go on to differentiate either into long-lived plasma cells capable of producing high affinity antibodies against foreign antigen, or germinal center-dependent memory B cells capable of quick immune re-activation in the future if ever the same antigen is re-encountered. TFH cells are also thought to facilitate negative selection of potentially autoimmune-causing mutated B cells in the germinal center. However, the biomechanisms by which TFH cells mediate germinal center tolerance are yet to be fully understood.

Regulatory B cells (Bregs or Breg cells) represent a small population of B cells that participates in immunomodulation and in the suppression of immune responses. The population of Bregs can be further separated into different human or murine subsets such as B10 cells, marginal zone B cells, Br1 cells, GrB+B cells, CD9+ B cells, and even some plasmablasts or plasma cells. Bregs regulate the immune system by different mechanisms. One of the main mechanisms is the production of anti-inflammatory cytokines such as interleukin 10 (IL-10), IL-35, or transforming growth factor beta (TGF-β). Another known mechanism is the production of cytotoxic Granzyme B. Bregs also express various inhibitory surface markers such as programmed death-ligand 1 (PD-L1), CD39, CD73, and aryl hydrocarbon receptor. The regulatory effects of Bregs were described in various models of inflammation, autoimmune diseases, transplantation reactions, and in anti-tumor immunity.

<span class="mw-page-title-main">RC3H1</span> Protein-coding gene in the species Homo sapiens

Ring finger and CCCH-type domains 1, also known as Roquin-1, is a protein that in humans is encoded by the RC3H1 gene.

<span class="mw-page-title-main">Bronchus-associated lymphoid tissue</span>

Bronchus-associated lymphoid tissue (BALT) is a tertiary lymphoid structure. It is a part of mucosa-associated lymphoid tissue (MALT), and it consists of lymphoid follicles in the lungs and bronchus. BALT is an effective priming site of the mucosal and systemic immune responses.

Patricia Gail Spear is an American virologist. She is a professor emeritus of microbiology and immunology at Northwestern University in Evanston, Illinois. She is best known for her pioneering work studying the herpes simplex virus. Spear is a past president of the American Society for Virology and an elected member of the National Academy of Sciences.

<span class="mw-page-title-main">George Mackaness</span> Australian immunologist (1922–2007)

George Bellamy Mackaness was an Australian professor of microbiology, immunologist, writer and administrator, who researched and described the life history of the macrophage. He showed that by infecting mice with intracellular bacteria, macrophages could be activated to attack other bacteria, triggering further research on "macrophage activation", a term he has come to be associated with.

Sidonia Făgărășan is a Romanian biological scientist who is a professor at the Riken Institute in Japan. Her research considers the molecular mechanisms that underpin processes in gut microbioata and the mucosal barrier. In 2020, she was awarded the Kobayashi Foundation Award.

References

  1. 1 2 3 4 Van Emmenis, Lucie (12 June 2023). "Michelle Linterman: We are always learning". Journal of Experimental Medicine. 220 (7): e20230900. doi:10.1084/jem.20230900. ISSN   0022-1007. PMC   10258648 . PMID   37306687.
  2. "Roll of graduates". Victoria University of Wellington. November 2023. Retrieved 6 March 2024.
  3. Linterman, Michelle A.; Rigby, Robert J.; Wong, Raphael. K.; Yu, Di; Brink, Robert; Cannons, Jennifer L.; Schwartzberg, Pamela L.; Cook, Matthew C.; Walters, Giles D.; Vinuesa, Carola G. (16 March 2009). "Follicular helper T cells are required for systemic autoimmunity". Journal of Experimental Medicine. 206 (3): 561–576. doi:10.1084/jem.20081886. ISSN   1540-9538. PMC   2699132 . PMID   19221396.
  4. Linterman, Michelle A; Denton, Alice E; Divekar, Devina P; Zvetkova, Ilona; Kane, Leanne; Ferreira, Cristina; Veldhoen, Marc; Clare, Simon; Dougan, Gordon; Espéli, Marion; Smith, Kenneth GC (27 October 2014). "CD28 expression is required after T cell priming for helper T cell responses and protective immunity to infection". eLife. 3. doi: 10.7554/eLife.03180 . ISSN   2050-084X. PMC   4241536 . PMID   25347065.
  5. "Dr Michelle Linterman". Churchill College. Retrieved 5 March 2024.
  6. Linterman, Michelle A; Pierson, Wim; Lee, Sau K; Kallies, Axel; Kawamoto, Shimpei; Rayner, Tim F; Srivastava, Monika; Divekar, Devina P; Beaton, Laura; Hogan, Jennifer J; Fagarasan, Sidonia; Liston, Adrian; Smith, Kenneth G C; Vinuesa, Carola G (August 2011). "Foxp3+ follicular regulatory T cells control the germinal center response". Nature Medicine. 17 (8): 975–982. doi:10.1038/nm.2425. ISSN   1078-8956. PMC   3182542 . PMID   21785433.
  7. "Michelle Linterman | Babraham Institute". www.babraham.ac.uk. Retrieved 4 March 2024.
  8. "Our Stories: Michelle Linterman". www.nzwomen.co.uk. Retrieved 5 March 2024.
  9. "Linterman lab at Babraham Institute uncovers reasons why our vaccine response declines with age". Cambridge Independent. 25 May 2023. Retrieved 5 March 2024.
  10. "Michelle Linterman » Babraham Institute". www.babraham.ac.uk. Retrieved 5 March 2024.
  11. 1 2 3 "Dr Michelle Linterman at Babraham Institute wins £250,000 Lister Prize for work on flu infection". Cambridge Independent. 14 July 2019. Retrieved 5 March 2024.
  12. "Fellow Profile: Dr Michelle Linterman". Lister Institute. 12 December 2019. Retrieved 5 March 2024.